Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Diana Bendixen"'
Autor:
Thierry Girard, Terasa Bulger, Sebastian Heiderich, Stephan Johannsen, Diana Bendixen, Anna Hellblom, H. Rüffert, Albert Urwyler, Klaus P.E. Glahn, V. Glauber, J.C. Brand, Philip M. Hopkins, A.F. Dalmas, Oscar Diaz-Cambronero, Pawan K. Gupta, R. L. Gillies, M. Snoeck, Helga Cristina Almeida da Silva, Frank Schuster, Börge Bastian, J.G. Bilmen, L. Heytens, A. Michalek-Sauberer, D. Štěpánková
Publikováno v:
British Journal of Anaesthesia. 126:120-130
Malignant hyperthermia is a potentially fatal condition, in which genetically predisposed individuals develop a hypermetabolic reaction to potent inhalation anaesthetics or succinylcholine. Because of the rarity of malignant hyperthermia and ethical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af543e33067ebcbea86e00f654fdd82
https://doi.org/10.1016/j.bja.2020.09.029
https://doi.org/10.1016/j.bja.2020.09.029
Autor:
M. Snoeck, Diana Bendixen, Philip M. Hopkins, Klaus P.E. Glahn, Albert Urwyler, H. Rüffert, Thierry Girard, Stephan Johannsen
Publikováno v:
British Journal of Anaesthesia. 125:133-140
Summary Faced with a malignant hyperthermia crisis, the immediate access to sufficient dantrolene is essential to achieve the best possible outcome for the patient. However, malignant hyperthermia crises are rare, and there may be administrative pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04eaafc4d28d061e599961a6a5f37cbd
https://doi.org/10.1016/j.bja.2020.04.089
https://doi.org/10.1016/j.bja.2020.04.089
Publikováno v:
Acta Anaesthesiologica Scandinavica. 46:1144-1149
Background: The in vitro contracture test (IVCT) is the golden standard to diagnose malignant hyperthermia susceptibility (MHS). A high reproducibility is important for a high validity of a test. Methods: We have therefore analyzed IVCT in 838 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc7fe1491e3d4854ab4f4089854a5001
https://doi.org/10.1034/j.1399-6576.2002.460914.x
https://doi.org/10.1034/j.1399-6576.2002.460914.x
Publikováno v:
Acta Anaesthesiologica Scandinavica. 41:967-972
Background In vitro contracture test (IVCT) for diagnosis of MH in our laboratory has a sensitivity of 100% and a specificity of 93%. The results are equivocal in 1&-15%, and supplementary tests may thus be required. We have tested the hypothesis tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d9d70dd2cb8e79e357f486544ba5bb2
https://doi.org/10.1111/j.1399-6576.1997.tb04821.x
https://doi.org/10.1111/j.1399-6576.1997.tb04821.x
Publikováno v:
Anesthesia and analgesia. 91(2)
The in vitro contracture test (IVCT) remains the standard test for the diagnosis of malignant hyperthermia (MH) susceptibility. The aim of this study was to investigate whether results of the IVCT varied between two diagnostic centers. The study took
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7844e860fe83f755fa44da400296b29b
https://pubmed.ncbi.nlm.nih.gov/10910867
https://pubmed.ncbi.nlm.nih.gov/10910867
Autor:
James J. A. Heffron, Kathleen A. Quane, Giacomo P. Comi, Clemens R. Müller, Tommie V. McCarthy, John O'Halloran, Albert Urwyler, Tore Fagerlund, Pat Vaughan, Koen Monsieurs, M. Lehane, Ording H, Bernadette M. Manning, Werner Wolz, L. Heytens, Vincenzo Tegazzin, K. Censier, Patrick J. Lynch, Diana Bendixen, Linda Giblin, E. Hartung
Publikováno v:
The American journal of human genetics
SummaryMalignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in genetically predisposed individuals by common anesthetics and muscle relaxants. The ryanodine receptor (RYR1) is mutated in a number of MH pedigr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235e25c79f1dca7faaba03fe3b97df36
https://europepmc.org/articles/PMC1376943/
https://europepmc.org/articles/PMC1376943/
Publikováno v:
Acta anaesthesiologica Scandinavica. 40(5)
Background: Malignant Hyperthermia (MH) is regarded as a dominantly inherited condition. Therefore, most investigators do not test the second parent if the first parent is found to be MH susceptible (MHS). The purpose of this study was to validate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b4f64c1eac8f10632066ea930c5cf4
https://pubmed.ncbi.nlm.nih.gov/8792888
https://pubmed.ncbi.nlm.nih.gov/8792888
Autor:
Diana Bendixen, Ording H
Publikováno v:
Malignant Hyperthermia ISBN: 9784431683483
The Danish Malignant Hyperthermia Register (DMHR) was created in 1977 [1] with the following aims: To collect information about cases of malignant hyperthermia (MH) To investigate these patients and their families To spread information about MH to pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7d34a343b68d4c886c17543dc04c097
https://doi.org/10.1007/978-4-431-68346-9_2
https://doi.org/10.1007/978-4-431-68346-9_2
Autor:
Ording H, T. H. Fagerlund, Diana Bendixen, E. Ranklev Twetman, Gunilla Islander, Kristian Berg
Publikováno v:
Europe PubMed Central
The ryanodine receptor 1 (RYR1) mutation C1840T has been reported to segregate with malignant hyperthermia (MH) susceptibility in several families. We have investigated several Scandinavian MH families with respect to five different RYR1 mutations re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::001b03f48d84a4b26d7de627a4d53922
http://europepmc.org/abstract/med/9520251
http://europepmc.org/abstract/med/9520251